Lenalidomide Monotherapy for Relapsed Mantle Cell Lymphoma episode artwork

EPISODE · Sep 3, 2013 · 7 MIN

Lenalidomide Monotherapy for Relapsed Mantle Cell Lymphoma

from Journal of Clinical Oncology (JCO) Podcast

Lenalidomide is a promising agent for the treatment of mantle cell lymphoma.

Episode metadata supplied by the publisher feed · Published Sep 3, 2013

Embed this episode

NOW PLAYING

Lenalidomide Monotherapy for Relapsed Mantle Cell Lymphoma

0:00 7:42

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Journal of Clinical Oncology (JCO) Podcast?

This episode is 7 minutes long.

When was this Journal of Clinical Oncology (JCO) Podcast episode published?

This episode was published on September 3, 2013.

Can I download this Journal of Clinical Oncology (JCO) Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!